NCT00241358View on ClinicalTrials.gov

Study Evaluating AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological Malignancies

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

December 31, 2009

Study Completion Date

February 28, 2010

Conditions
Leukemia, Myeloid, AcuteLeukemia, Myelogenous, ChronicLeukemia, Lymphoblastic, AcuteLymphocytic Leukemia, ChronicMyelodysplastic SyndromesMultiple MyelomaLymphoma, Non-HodgkinHodgkin Disease
Interventions
DRUG

AMD3100

PROCEDURE

Stem Cell Transplant

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT00241358 - Study Evaluating AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological Malignancies | Biotech Hunter | Biotech Hunter